Introduction : 
A randomized controlled trial revealed that initiating daily emollient use within 4 days of birth and maintaining it for the first 2 months significantly reduced the incidence of atopic dermatitis (AD) at 12 months by 29% in high-risk infants, compared to standard care.This study indicates that early and short-term emollient use can help prevent AD in high-risk infants.